Starting a Supplement Company

Starting a supplement company in the United States usually means choosing a focused product, hiring a qualified contract manufacturer, building a compliant label and claims file, selecting packaging that protects the formula, and keeping enough cash for testing and the second production run. FDA does not approve dietary supplements before sale, but the company selling them remains responsible for safety, labeling, claims, complaint handling, and regulatory compliance.

The sequence matters. Founders who design a label before confirming the formula, bottle, serving count, and manufacturer specifications often pay for avoidable revisions. Founders who spend the whole budget on the first batch can reach launch day without enough cash to market or reorder it.

Choose a Launch Model Before You Choose Ingredients

The first decision is not whether to sell magnesium, collagen, or an herbal blend. It is how much product control, speed, and inventory risk the business can support. Suppliers use “white label” and “private label” inconsistently, so compare formula ownership, exclusivity, change rights, testing, and minimums rather than relying on the name of the program.

White Label Is the Fastest Market Test

A white label product uses an existing formula and usually an existing package selected from a manufacturer's catalog. The founder supplies the brand, label artwork, sales channel, and marketing plan while accepting limited control over the formulation.

This model works when the goal is to test a customer, offer, or channel without funding custom development. The tradeoff is weak differentiation because another brand may sell the same underlying formula.

Private Label Adds Brand Control Without Full Development

Private label programs normally offer a stock or lightly configurable formula with choices around dosage, flavor, bottle, closure, count, and label. They require more coordination than white label, but they can preserve a faster timeline than a formula built from scratch.

Private label is often the practical first step for a founder who has clear positioning but has not yet proven demand. It creates room to improve packaging and customer experience without placing every dollar into formulation work.

Custom Formulation Buys Differentiation at a Cost

A custom product can control ingredients, dose, excipients, flavor system, dosage form, and intellectual property terms. It also adds formulation work, sourcing risk, pilot samples, analytical testing, stability questions, and generally larger minimum production runs.

Custom formulation makes more sense when the brand has validated demand or when the formula itself is the defensible product. It is a poor default when the founder has not yet tested price, acquisition cost, or repeat purchase behavior.

Build the Full Startup Budget Before Requesting Quotes

There is no official startup cost for a supplement company. The U.S. Small Business Administration recommends separating one time expenses from monthly expenses and accounting for inventory, insurance, professional services, licenses, marketing, and working capital.

A manufacturer's production quote is therefore not the launch budget. It may omit brand development, label review, independent testing, insurance, freight, storage, ecommerce fees, customer acquisition, and the cash deposit for a reorder.

One April 2026 operating model from Inventory Ready places a single 5,000 unit capsule launch at $14,200 to $29,500 and a comparable gummy launch at $31,000 to $56,000. The source describes these bands as orientation from operational experience, not survey data, and excludes branding, legal review, insurance, paid acquisition, and some channel costs. Replace the scenario with at least two itemized manufacturer quotes before committing capital.

Separate One Time and Recurring Costs

Entity formation, trademark work, initial label design, formula development, photography, and some setup charges are primarily launch expenses. Manufacturing, packaging, testing, freight, insurance, storage, software, and marketing continue after the first sale.

This separation matters when evaluating unit economics. A first run may appear unprofitable after absorbing every setup expense, while a second run improves because the formula, artwork, and packaging specification already exist.

Keep Reorder Cash Outside the Launch Budget

A product that sells through but cannot be reordered is not a successful launch. Contract manufacturers commonly require deposits, and the next batch may enter the schedule weeks before the current one runs out.

Reserve reorder cash before deciding how much to spend on custom packaging or launch creative. The practical question is not only whether the first order is affordable, but whether the business can pay for the second order while the first batch is still turning into cash.

Supplement brand planning with bottle and capsule samples

Select One Product, One Customer, and One Sales Channel

A first product should solve a defined customer problem without forcing the company to manage several formulas, labels, inventory forecasts, and claim files at once. One product also makes manufacturing quotes easier to compare because every supplier receives the same formulation brief, serving count, dosage form, testing plan, and packaging specification.

The dosage form changes the entire operating model. Capsules and tablets usually fit packer or round bottles, powders may need wide mouth containers and scoops, gummies create moisture and sticking concerns, and liquid supplements require formula specific compatibility and dispensing tests.

The primary sales channel changes the package as well. Direct to consumer shipping rewards low breakage and efficient case packing, Amazon adds marketplace preparation requirements, and retail buyers may require tamper evidence, specific case quantities, barcodes, insurance, and longer payment terms.

Write the product brief before approaching manufacturers. It should define the target user, serving format, ingredient direction, target retail price, sales channel, expected first run, required certifications, target launch date, and packaging assumptions.

Form the Business and Map Regulatory Responsibilities

The brand needs an appropriate legal entity, tax registrations, banking, insurance, contracts, and any state or local permits that apply to its activities. The SBA licensing guide notes that requirements vary by business activity, location, and issuing agency, so there is no universal supplement business license that replaces state and local research.

Dietary supplements are regulated differently from conventional foods and drugs. The FDA dietary supplement overview states that manufacturers and distributors are responsible for evaluating safety and labeling before marketing and for ensuring that products are not adulterated or misbranded.

A founder should also distinguish a brand entity from the physical facilities that manufacture, pack, or hold food. FDA facility registration obligations generally attach to covered facilities, subject to exemptions, rather than automatically requiring every brand owner to register a separate office.

Outsourcing production does not outsource every responsibility. Contracts should identify who owns the formula, approves specifications, releases batches, maintains records, reviews labels, handles complaints, manages recalls, files required notifications, and carries which insurance.

The postmarket system must also exist before the first sale. FDA's adverse event reporting guidance explains that a responsible person receiving a serious adverse event report must submit it to FDA no later than 15 business days after receipt, with follow up reports required when qualifying new medical information arrives.

Vet the Contract Manufacturer as a Quality System

A manufacturer should be evaluated on the operations it performs, not on a badge placed in a website footer. The binding federal requirements sit in 21 CFR Part 111, which covers personnel, facilities, equipment, production controls, quality control, components, packaging, labels, laboratory operations, records, complaints, and distribution.

FDA's small entity compliance guide for dietary supplement CGMP explains that firms remain responsible for the provisions applying to the operations they perform. A distributor using a contract manufacturer still needs enough visibility into those activities to make informed decisions about specifications and product release.

Verify the Audit, Not Just the Phrase GMP

FDA requires CGMP compliance, but “FDA registered” does not mean FDA approved. Registration is an administrative requirement, while compliance depends on the facility's actual quality system and inspection history.

Ask for the scope and date of the most recent independent audit, the corrective action process, and documentation showing that the facility and dosage form are covered. NSF describes NSF/ANSI 455-2 as a dietary supplement GMP audit standard encompassing regulatory requirements, retailer requirements, and industry practices.

Review Specifications, Testing, and Batch Release

Request a sample certificate of analysis, an explanation of incoming ingredient identity testing, finished product specifications, laboratory methods, out of specification procedures, and the person authorized to release a batch. A polished sales deck is not a substitute for these records.

FDA makes dietary supplement and food related warning letters publicly searchable. They can help a buyer understand the kinds of manufacturing, labeling, and claim failures regulators are finding, although a historical letter should be read with any later closeout or corrective context.

Compare Manufacturers With the Same Brief

Send every serious candidate the same formula direction, dosage form, count, testing expectations, packaging specification, first run quantity, and timeline. A low quote based on a stock bottle and minimal testing cannot be compared directly with a quote that includes custom development, independent testing, decorated packaging, and freight.

Ask who purchases the packaging and who bears the risk if the bottle, closure, liner, label, or filling line is incompatible. Also confirm production tolerances, deposit terms, overrun and underrun policy, artwork deadlines, ownership of tooling, reorder lead time, and the documents delivered with each batch.

Lock Claims and Label Architecture Before Printing

FDA does not preapprove a supplement label, but the label still has required elements. The agency's Dietary Supplement Labeling Guide covers the statement of identity, net quantity, Supplement Facts, ingredient declarations, name and place of business, and other labeling questions. The responsible person's domestic address or phone number must also support serious adverse event reporting from the label.

The formula, serving size, ingredient quantities, warnings, manufacturer or distributor statement, and package dimensions all affect the artwork. Printing labels before the final product and package specification is approved creates a relabeling risk.

Structure and Function Claims Need Their Own File

A supplement may use qualifying structure and function statements, but those statements cannot claim to diagnose, treat, cure, or prevent disease. FDA's structure and function claims guide explains that the company needs substantiation before making the claim, must use the required disclaimer, and must notify FDA within 30 days after first marketing a product bearing the claim.

Marketing copy creates separate exposure. The FTC Health Products Compliance Guidance says both express and implied health claims need appropriate substantiation and that objective health claims generally require competent and reliable scientific evidence.

Check New Dietary Ingredient Status Early

A custom formula may raise a new dietary ingredient question. FDA's NDI background for industry explains that an ingredient not marketed in the United States as a dietary supplement before October 15, 1994 may require a safety based notification at least 75 days before introduction into interstate commerce, unless an exception applies.

There is no authoritative master list of every pre 1994 ingredient. Ingredient status and the chemical form being used therefore belong in the regulatory review before the company commits to a custom formula or launch date.

Supplement bottle closure and package quality control samples

Specify Packaging as a Complete System

The bottle is one component of a package that also includes the closure, liner, tamper evidence when selected, desiccant or insert when used, label, lot code, expiration marking when used, shipper case, and filling process. Changing one component can affect seal integrity, line performance, label fit, moisture control, and the amount of product that fits.

Do not assume every dietary supplement is subject to a universal federal tamper evidence mandate. Tamper features may be driven by product risk, retailer or marketplace requirements, channel expectations, or a product specific rule, so confirm the requirement for the actual formula and sales path.

Part 111 requires specifications for packaging that contacts dietary supplements. Section 111.70 states that contact packaging must be safe and suitable for its intended use and must not be reactive, absorptive, or otherwise affect product safety or quality.

Propacks' supplement packaging guide explains how product format, bottle material, color, closure, neck finish, and dose count shape the selection. Its live Supplement Bottles collection provides stock 2 oz, 4 oz, and 8 oz formats with matching closure options and no minimum order requirement.

A usable packaging specification should identify bottle resin and recycled content, capacity, color, dimensions, neck finish, closure, liner, tamper feature, label panel, decoration method, case pack, and acceptance criteria. The manufacturer should approve that specification against its filling and capping equipment before the brand authorizes a production order. FDA's labeling guide says expiration dating is not generally required for dietary supplements, but a date used on the label should be supported by valid data.

Test the Formula, Package, and Filling Process Together

A bottle that looks correct when empty can fail after filling. Oils may interact with liners, hygroscopic powders may need stronger moisture control, liquid formulas may leak through a mismatched closure, and a label that fits a digital template may lift on a curved or tapered panel.

Begin with physical samples. Propacks' packaging sample guide covers visual inspection, closure fit, dispensing, label trials, and formula compatibility work before a larger order.

Compatibility testing should use the finished formula, intended fill volume, actual closure, expected storage orientation, and realistic temperature conditions. The chemical compatibility testing guide explains accelerated aging, weight change, migration, stress cracking, sensory checks, and dimensional inspection.

The first filled pilot should also test capping torque, liner compression, tamper evidence, lot coding, label application, case packing, and shipping. Record the approved combination as a controlled specification rather than relying on a bottle name in an email thread.

Size the First Order Around Sell Through and Reorder Time

The manufacturer's minimum batch and the packaging supplier's minimum order are different constraints. A turnkey manufacturer may bundle packaging into its quote, while a brand supplying its own components may be able to test several bottle and closure combinations without buying the entire production quantity first.

Propacks carries stock packaging without a minimum order on most listed components. That lets a brand buy samples, conduct a pilot, and hold a limited replacement reserve without committing to a custom packaging run before product demand is proven.

Set the production quantity from a conservative sales forecast rather than the lowest unit price shown on a large volume quote. The reorder point is expected demand during the manufacturing and packaging lead time plus an explicit safety stock allowance.

A cheaper unit cost can still be an expensive decision if inventory sits for a year, the label changes, or the formula needs revision. The packaging lead time guide can be used with the manufacturer's production schedule to determine when the second packaging and production orders must begin.

Stock supplement bottles and cartons for a first production order

Build a Launch Sequence That Prevents Rework

Start with the customer, product concept, price, launch model, channel, and total cash limit. Move next to a common manufacturer brief and compare qualified partners on the same scope.

After selecting the provisional manufacturer, finalize formula direction, ingredient status, specifications, testing, claims, and label architecture. Approve the bottle and closure only after the manufacturer confirms line fit and the formula passes the planned package tests.

Release printed labels and production packaging after the formula, serving information, warnings, package dimensions, and lot coding plan are controlled. Keep independent testing, insurance, fulfillment setup, customer complaint procedures, and reorder cash on the launch plan rather than treating them as work for after the first sale.

The final commercial gate is simple: the company should know who releases the batch, what documents prove it met specifications, where each lot is stored and shipped, how a complaint reaches a responsible person, and how the next batch will be financed. If those answers are unclear, the product is not ready for traffic.

A packaging adviser can help turn the approved formula, serving count, and filling requirements into a sample set and component specification. Brands can contact Propacks to compare stock supplement bottle and closure combinations before committing to the first full order.